EQUIPE
Dr. Daniel Cubero
Oncologista
CRM: 98.992
– Diretor Executivo e Investigador CEPHO
– Médico e Docente FMABC
Título de Doutorado em Ciências da Saúde
2015
Especialidade: Cancerologia Clínica
2013
Título Especialista Oncologia Clínica
2005
Título Especialista Cancerologia
2005
Homenagem Harvard
2013
Harvard 4 Day Workshop
2012
Harvard PPCR
2012
Mestrado em Ciências da Saúde - Área de Concentração: Medicina
2010
Residência Médica Especialista em Oncologia - AC Camargo
2005
Fundamentos Básicos para Profissionais de Pesquisa Clínica
2005
Residência Clínica Médica
2002
Certificado Ético Profissional
2000
Diploma de Medicina
2000
- Professor da disciplina de Oncologia na Faculdade de Medicina do ABC
- Pesquisador Principal no CEPHO
Enzalutamide and Survival in Nonmetastatic,
Castration-Resistant Prostate Cancer
2020
Evaluation of the systemic and therapeutic
repercussions caused by drug interactions in
oncology patients
2019
The efficacy of placebo for the treatment of cancer-related fatigue: a systematic review and meta-analysis
2019
The feasibility of dexamethasone omission in weekly paclitaxel treatment for breast cancer patients
2018
Epidemiological profile of Brazilian oncological
patients seen by a reference oncology center of the public health system and who migrate in search of adequate health care
2018
Cutaneous side effects of molecularly targeted therapies for the treatment of solid tumors
2018
Medical Student Oncology Congress: Designed and Implemented by Brazilian Medical Students
2017
Curcuma longa (Turmeric) for Prevention of
Capecitabine-Induced Hand-Foot Syndrome: A
Pilot Study
2017
Purified Dry Paullinia cupana (PC-18) Extract for
Chemotherapy-Induced Fatigue: Results of Two
Double-Blind Randomized Clinical Trials
2017
Uncaria tomentosa (Cat’s Claw) Improves Quality
of Life in Patients with Advanced Solid Tumors
2015
Biomarkers of fatigue related to adjuvant
chemotherapy for breast cancer: evaluation of
plasma and lymphocyte expression
2015
Bournout in Medical Oncology Fellows: a Prospective Multicenter Cohort Study in Brazilian Institutions
2015
Pain and quality of life in patients undergoing radiotherapy for spinal metastatic disease
treatment
2013
Tegafur-uracil (UFT) in lower doses is
safe for the treatment of colorectal cancer in patients with partial dihydropyrimidine
dehydrogenase deficiency: a proof of
principle
2013
Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial
2013
Tegafur–uracil is a safe alternative for
the treatment of colorectal cancer in
patients with partial dihydropyrimidine
dehydrogenase deficiency: a proof
of principle
2012
Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients
2012
Gabapentin for the prevention of chemotherapy- induced
nausea and vomiting: a pilot study
2011
Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study
2009
Andrea Kazumi Shimada
Danielle Mauricio Cabral Amaro